Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3/5
GC Biopharma Corp (006280 KS)
Watchlist
101
Analysis
Health Care
•
South Korea
GC Biopharma is a biopharmaceutical company headquartered in Yongin, South Korea. It manufactures household medical drugs. The Company's product includes medicines for cold and fever, nutrition, antiseptic drug, and a lip balm.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Quantitative Analysis
•
06 Apr 2020 02:07
What Local Institutions Buy in KOSPI: Screening Low Capital Risk & High Div Stocks
What are the local institutions buying in KOSPI? Below is the top 20 list of the most purchased stocks (in terms of net bought value as a % of...
Sanghyun Park
Follow
360 Views
Share
bullish
•
China Everbright
•
06 Feb 2018 23:58
StubWorld - Set-Up & Unwind Extremes: China Everbright; Green Cross
This week: China Everbright Ltd (165 HK) is around the "cheapest" inside a year, with various opportunities to monetise assets expected in 2018;...
David Blennerhassett
Follow
389 Views
Share
bullish
•
Enzychem Lifesciences Corp
•
02 Feb 2018 13:52
Enzychem Lifesciences New IPO Book Summary
Enzychem Lifesciences Corp (183490 KS) submitted the revised version of IPO book on Jan 22. Here is the link of this new IPO...
Sanghyun Park
Follow
373 Views
Share
bullish
•
Enzychem Lifesciences Corp
•
20 Jan 2018 20:15
Enzychem Lifesciences IPO Rescheduling Summary
Enzychem Lifesciences Corp (183490 KS), which is Korea's first major and serious IPO this year, announced (around 6 PM Friday Jan 19) that it had...
Sanghyun Park
Follow
368 Views
Share
bullish
•
Samsung C&T
•
16 Oct 2017 06:58
Samsung Restructuring Update - Local Institutions Are Scooping Up Samsung C&T
Check this. The stock that ranked top in the local institutions' top 10 net buying stock list for last week (Oct 10-13) is Samsung C&T Corp...
Sanghyun Park
Follow
372 Views
Share
First
Previous
6
7
8
9
10
11
12
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x